- Home
- NKTX vs EMF Comparison
NKTX vs EMF Comparison
Compare NKTX & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- EMF
- Stock Information
- Founded
- NKTX 2015
- EMF 1987
- Country
- NKTX United States
- EMF United States
- Employees
- NKTX N/A
- EMF N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- EMF Finance/Investors Services
- Sector
- NKTX Health Care
- EMF Finance
- Exchange
- NKTX Nasdaq
- EMF Nasdaq
- Market Cap
- NKTX 170.8M
- EMF 192.8M
- IPO Year
- NKTX 2020
- EMF N/A
- Fundamental
- Price
- NKTX $2.47
- EMF $12.07
- Analyst Decision
- NKTX Strong Buy
- EMF
- Analyst Count
- NKTX 5
- EMF 0
- Target Price
- NKTX $15.20
- EMF N/A
- AVG Volume (30 Days)
- NKTX 1.5M
- EMF 29.3K
- Earning Date
- NKTX 11-07-2024
- EMF 01-01-0001
- Dividend Yield
- NKTX N/A
- EMF 6.16%
- EPS Growth
- NKTX N/A
- EMF N/A
- EPS
- NKTX N/A
- EMF N/A
- Revenue
- NKTX N/A
- EMF N/A
- Revenue This Year
- NKTX N/A
- EMF N/A
- Revenue Next Year
- NKTX N/A
- EMF N/A
- P/E Ratio
- NKTX N/A
- EMF N/A
- Revenue Growth
- NKTX N/A
- EMF N/A
- 52 Week Low
- NKTX $2.08
- EMF $10.58
- 52 Week High
- NKTX $16.24
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- NKTX 50.49
- EMF 46.50
- Support Level
- NKTX $2.19
- EMF $11.71
- Resistance Level
- NKTX $2.70
- EMF $12.29
- Average True Range (ATR)
- NKTX 0.15
- EMF 0.12
- MACD
- NKTX 0.03
- EMF 0.03
- Stochastic Oscillator
- NKTX 54.90
- EMF 62.07
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.